Selected Work · 2026 / McCay Barnes

Delightful design with clinical integration, hardened through design controls.

LIVE TRACEEX-PREEMIE · MILD BPD · BASELINE 91% · ILLUSTRATIVE DATA NOW · 21:00
CLINICAL 90% fixed PERSONAL 88% adaptive 100% 95 90 85 80 22:30 SLEEP TRANSITION 01:00 FEED APNEA 05:00 PERIODIC BREATHING 07:00 PROBE DISPLACEMENT REAL DESAT EVENT · 03:00 86% · 90 s sustained
21:0000:0003:0006:0009:00
/ Selected Work
Claim 01

Warm handoffs at data scale.

Some patients need a clinician's attention but never get it. Not because the model is wrong, but because no human can review every overnight SpO₂ trace or call every post-cataract patient daily. AI absorbs the data volume that was hiding those patients, then delivers a warm handoff a clinician can act on. Two domains, same posture: NICU monitoring that surfaces the overnight trace a neonatologist needs to see; post-cataract symptom check-ins that route escalations into same-day call-backs with the transcript pre-loaded. Both examples are AI evals. The pipeline and scoring are real, based on synthetic patient data.

Claim 02

Pathways no one's built yet.

Most new growth in regulated healthcare lives in pathways that haven't been built yet. The blocker isn't ideas. It's the cost of working one up to a fundable proposal: provider workflow design, patient journey mapping, evidence-to-design synthesis, illustrative care planning that survives clinical review. Months of work per concept. The skill that produced the sarcopenia pathway on this site does all four in an afternoon. What you get isn't a launch-ready product. It's a fundable proposal with real substance, end-to-end. The unlock is bringing 10 of these to a budget conversation instead of one. The decision shifts from "should we bet on this" to "which of the ten is worth the deeper investment."

/ How I Work
Claim 01

Design controls in hours. Tied to code.

Design control drafts traditionally chase the code: weeks of asking dev for context, scheduling reviewer sessions, getting shallow drafts back. SaMD-OS inverts that. It generates design controls, hazard analyses, and SOUP registers directly from the codebase, anchored to pinned standards, then runs five specialist reviewers (regulatory, QA, safety, cybersecurity, clinical) in parallel. The most conservative verdict wins. Hours of detailed drafts, instead of weeks of shallow ones. The drafts feed your eQMS; the eQMS still owns the approved record.

Claim 02

v5 in v1 time.

Working code is the easy part. The iteration happens before the first line of code: multiple Claude sessions stress-test the framing, the spec, and the plan, and specialist persona reviewers (clinical, regulatory, safety, cybersecurity) red-team the plan against pinned standards. By the time code lands, v5 of the idea is on the page. One live pass catches integration issues. What reaches your calendar is fully formed, not half-baked.

Claim 03

From client question to board case.

Data-product strategy sprawls across decks, memory, and one-off analyses, and every PM runs it differently. PM-OS makes it one versioned toolkit: a client use case runs through a data-feasibility verdict and an evidence-bar review, then a business-case engine sizes the opportunity and a right-to-win skeptic pressure-tests every number before the board sees it. The PM still owns the call; the data team still builds. Same playbook, every PM.

Playground